StockData
Bionano Genomics, Inc. logo

Bionano Genomics, Inc. (BNGO) stock

BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.98+0.02 (+2.50%)

Close on Nov 18, 2026Market cap $11.49MP/E –Yield –

Bionano Genomics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Bionano Genomics's pe ratio was 0.1× on Oct 31, 2018.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2018Oct 31, 20180.1×–

More Bionano Genomics figures

See a number that looks wrong?